CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,819,546
+$3,933,536 QoQ
Shares Held
1,492,367
+9.8% QoQ
Ownership
0.819%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. XERS ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in XERS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,819,546 | 1,492,367 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,886,010 | 1,359,657 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,020,018 | 1,403,824 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,775,478 | 1,446,619 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,650,402 | 567,538 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,326,524 | 423,775 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,365,736 | 402,872 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,149,578 | 403,361 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $910,309 | 404,582 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $809,507 | 366,293 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $856,297 | 364,382 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $678,924 | 365,013 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $956,334 | 365,013 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $611,235 | 374,991 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $463,155 | 348,237 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $527,010 | 337,827 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $521,120 | 338,390 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $121,515 | 47,467 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $196,339 | 67,010 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||